USANA Health Sciences (USNA) Tops Q4 EPS by 15c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $13.84 -6.93%
Financial Fact:
Earnings before income taxes: 36.1M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Earnings before income taxes: 36.1M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $0.64, $0.15 better than the analyst estimate of $0.49. Revenue for the quarter came in at $214 million versus the consensus estimate of $208.84 million.
GUIDANCE:
USANA Health Sciences sees FY2025 EPS of $2.35-$3.00, versus the consensus of $2.87. USANA Health Sciences sees FY2025 revenue of $920-1000 million, versus the consensus of $934.5 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crude Inventory Fell 0.9 Million Barrels Last Week - EIA
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- Sportradar Group AG (SRAD) PT Raised to $16 at StoneX
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
